Analysts who follow CSL Ltd. are increasingly confident the company will reap windfall profits from a cancer vaccine in development by U.S. partner Merck & Co. After market updates by both companies
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/csl-expected-reap-profit-cancer-vaccine
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/asian-wall-street-journal-hong-kong
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health